Orbimed Advisors - ANACOR PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
Orbimed Advisors ownership history of ANACOR PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2016$2,849,000
-52.7%
53,3000.0%0.03%
-45.5%
Q4 2015$6,021,000
-4.0%
53,3000.0%0.06%
-12.7%
Q3 2015$6,274,000
-37.2%
53,300
-58.7%
0.06%
-13.7%
Q2 2015$9,988,000129,0000.07%
Other shareholders
ANACOR PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RHO CAPITAL PARTNERS INC 1,067,892$120,640,00041.48%
Palo Alto Investors LP 2,187,242$247,093,00013.75%
VHCP Management, LLC 140,756$15,901,0009.61%
HWG Holdings LP 48,910$5,525,0005.62%
KINGDON CAPITAL MANAGEMENT, L.L.C. 906,287$102,383,0004.98%
Baker Brothers Advisors 4,198,520$474,307,0003.93%
Asymmetry Capital Management, L.P. 15,591$1,761,0002.66%
NEXT CENTURY GROWTH INVESTORS LLC 496,744$56,117,0002.42%
AlpInvest Partners B.V. 11,551$1,305,0002.17%
Atika Capital Management LLC 36,000$4,067,0002.09%
View complete list of ANACOR PHARMACEUTICALS INC shareholders